ALDORO RESOURCES LIMITED For personal use only
ASX and Media Release
17 February 2022
Thickest Niobe Pegmatite Intersections Encountered During Phase III Drilling
HIGHLIGHTS:
- Thirteen (13) more RC holes have been completed at Niobe, for a total of 45 completed to date.
- All 13 holes intersected pegmatite intervals at multiple intervals below the surface.
- Best pegmatite intersections highlighted by two intersections recording 17m thickness of pegmatite (NBCRO35, NBCRO43), one with 18m of pegmatite (NBCRO44) and an exceptional 26m of pegmatite recovered from hole NBCRO45.
- Pegmatites appear
- Assay results awaited which will confirm Lithium and Rubidium grade of the intersected pegmatites
Aldoro Resources Limited (Aldoro, The Company) (ASX: ARN) is pleased to provide an exploration drilling update for the Niobe Project. A further thirteen holes have been completed (NBRCO33- NBRCO45) in the interim, with all holes intersecting pegmatites. The full results of these holes will be announced when geological logs, systematic pXRF readings, and QAQC checks are completed. The reader is referred to Table 1 for a summary of pegmatite intersections to date.
Figure 1. RC rig operating at Niobe.
The results of this third phase of drilling at Niobe continue to encourage, with intersections of pegmatites confirming historical drilling and exceeding expectations. Two intersections have recorded 17m thickness of pegmatite (NBCRO35, NBCRO43), one with 18m of pegmatite (NBCRO44) and an exceptional 26m of pegmatite recovered from hole NBCRO45. Full details of the pegmatite
For personal use only
intersections will be announced when detailed logging, pXRF, and QAQC checks are completed.
All intersections are routinely scanned at 1m intervals with a portable XRF (pXRF), to obtain real-time data and to aid fast-track interpretation and in-field planning. The pXRF results will be reported as they come to hand.
Figure 2. Photograph of drill samples collected from Phase III drilling (Drill hole NBRCO41).
Forward Plan
The drilling program is ongoing to completion, with the aim of estimating a JORC2012 reportable Mineral Resource when all assay results have been received.
Once the Niobe drilling program is completed, the RC rig will then mobilise to the Wyemandoo Project, where an extensive greenfields pegmatite drilling program has been planned.
Note: The reader is referred to the previous Table 1 in the ASX announcement 04 February 2022. The drill hole data presented here does not materially affect the information included in the previous market announcements and, in the case of estimates of mineral resources, that all material assumptions and technical parameters underpinning the estimates in the previous market announcement continue to apply and have not materially changed.
Hole ID | Length | Dip | Azimuth | From | To | Pegmatite | Rb Grade | Li Grade | |
only | |||||||||
m | m | Width m | % | % | |||||
NBRC001 | 52 | -60 | 180 | 12 | 15 | 3 | Assays Awaited | ||
20 | 25 | 5 | Assays Awaited | ||||||
NBRC002 | 60 | -60 | 180 | 28 | 30 | 2 | Assays Awaited | ||
40 | 41 | 1 | Assays Awaited | ||||||
NBRC003 | 50 | -60 | 180 | 0 | 12 | 12 | Assays Awaited | ||
use | |||||||||
28 | 32 | 4 | Assays Awaited | ||||||
NBRC004 | 64 | -60 | 180 | 25 | 26 | 1 | Assays Awaited | ||
39 | 41 | 2 | Assays Awaited | ||||||
57 | 59 | 2 | Assays Awaited | ||||||
NBRC005 | 64 | -60 | 180 | 16 | 20 | 4 | Assays Awaited | ||
personal | 47 | 58 | 11 | Assays Awaited | |||||
NBRC011 | 80 | -60 | 180 | 1 | 2 | 1 | Assays Awaited | ||
NBRC006 | 66 | -60 | 180 | 10 | 17 | 7 | Assays Awaited | ||
44 | 61 | 17 | Assays Awaited | ||||||
NBRC007 | 70 | -60 | 180 | 16 | 24 | 8 | Assays Awaited | ||
48 | 64 | 16 | Assays Awaited | ||||||
NBRC008 | 60 | -60 | 180 | 3 | 11 | 8 | Assays Awaited | ||
36 | 57 | 21 | Assays Awaited | ||||||
NBRC009 | 54 | -60 | 180 | 6 | 17 | 11 | Assays Awaited | ||
40 | 54 | 14 | Assays Awaited | ||||||
NBRC010 | 60 | -60 | 180 | 1 | 18 | 17 | Assays Awaited | ||
46 | 57 | 11 | Assays Awaited | ||||||
For | |||||||||
11 | 24 | 13 | Assays Awaited | ||||||
17 | 26 | 9 | Assays Awaited | ||||||
53 | 62 | 9 | Assays Awaited | ||||||
NBRC012 | 80 | -60 | 180 | Data Unavailiable | |||||
NBRC013 | 60 | -60 | 180 | 0 | 10 | 10 | Assays Awaited | ||
28 | 30 | 2 | Assays Awaited | ||||||
32 | 33 | 1 | Assays Awaited | ||||||
NBRC014 | 60 | -60 | 180 | 1 | 8 | 7 | Assays Awaited | ||
10 | 14 | 4 | Assays Awaited | ||||||
15 | 16 | 1 | Assays Awaited | |||||
only | 23 | 30 | 7 | Assays Awaited | ||||
36 | 37 | 1 | Assays Awaited | |||||
NBRC015 | 60 | -60 | 180 | 0 | 15 | 15 | Assays Awaited | |
24 | 29 | 5 | Assays Awaited | |||||
36 | 37 | 1 | Assays Awaited | |||||
NBRC016 | 60 | -60 | 180 | 3 | 7 | 4 | Assays Awaited | |
use | ||||||||
15 | 17 | 2 | Assays Awaited | |||||
25 | 26 | 1 | Assays Awaited | |||||
NBRC017 | 50 | -60 | 180 | 2 | 6 | 4 | Assays Awaited | |
8 | 14 | 6 | Assays Awaited | |||||
15 | 20 | 5 | Assays Awaited | |||||
personal | 25 | 30 | 5 | Assays Awaited | ||||
38 | 40 | 2 | Assays Awaited | |||||
NBRC018 | 50 | -60 | 180 | 9 | 16 | 7 | Assays Awaited | |
20 | 24 | 4 | Assays Awaited | |||||
30 | 34 | 4 | Assays Awaited | |||||
42 | 44 | 2 | Assays Awaited | |||||
NBRC019 | 50 | -60 | 180 | 0 | 6 | 6 | Assays Awaited | |
7 | 8 | 1 | Assays Awaited | |||||
17 | 19 | 2 | Assays Awaited | |||||
42 | 44 | 2 | Assays Awaited | |||||
NBRCO20 | 62 | -60 | 180 | 7 | 15 | 8 | Assays Awaited | |
20 | 27 | 7 | Assays Awaited | |||||
For | ||||||||
35 | 36 | 1 | Assays Awaited | |||||
47 | 48 | 1 | Assays Awaited | |||||
52 | 57 | 5 | Assays Awaited | |||||
NBRCO21 | 60 | -60 | 180 | 0 | 15 | 15 | Assays Awaited | |
23 | 25 | 2 | Assays Awaited | |||||
27 | 28 | 1 | Assays Awaited | |||||
NBRCO22 | 60 | -60 | 180 | 6 | 12 | 6 | Assays Awaited | |
18 | 24 | 6 | Assays Awaited | |||||
NBCRO23 | 60 | -60 | 180 | 4 | 7 | 3 | Assays Awaited | |
16 | 23 | 7 | Assays Awaited | |||||
only | 44 | 45 | 1 | Assays Awaited | ||||
NBCRO24 | 60 | -60 | 180 | 3 | 12 | 9 | Assays Awaited | |
16 | 17 | 1 | Assays Awaited | |||||
25 | 29 | 4 | Assays Awaited | |||||
NBCRO25 | 50 | -60 | 180 | 2 | 11 | 9 | Assays Awaited | |
17 | 19 | 2 | Assays Awaited | |||||
use | ||||||||
22 | 29 | 6 | Assays Awaited | |||||
NBCRO26 | 40 | -60 | 180 | 0 | 1 | 1 | Assays Awaited | |
11 | 21 | 10 | Assays Awaited | |||||
NBCRO27 | 60 | -60 | 180 | 12 | 16 | 4 | Assays Awaited | |
23 | 26 | 3 | Assays Awaited | |||||
personal | 29 | 30 | 1 | Assays Awaited | ||||
49 | 51 | 2 | Assays Awaited | |||||
NBCRO28 | 40 | -60 | 180 | 4 | 12 | 8 | Assays Awaited | |
15 | 17 | 2 | Assays Awaited | |||||
NBCRO29 | 40 | -60 | 180 | 8 | 17 | 9 | Assays Awaited | |
NBCRO30 | 60 | -60 | 180 | 0 | 2 | 2 | Assays Awaited | |
7 | 11 | 4 | Assays Awaited | |||||
13 | 15 | 2 | Assays Awaited | |||||
27 | 31 | 4 | Assays Awaited | |||||
NBCRO31 | 60 | -60 | 180 | 5 | 6 | 1 | Assays Awaited | |
20 | 21 | 1 | Assays Awaited | |||||
25 | 26 | 1 | Assays Awaited | |||||
For | ||||||||
31 | 32 | 1 | Assays Awaited | |||||
33 | 36 | 3 | Assays Awaited | |||||
NBCRO32 | 62 | -60 | 180 | 16 | 20 | 4 | Assays Awaited | |
29 | 30 | 1 | Assays Awaited | |||||
32 | 34 | 2 | Assays Awaited | |||||
39 | 50 | 10 | Assays Awaited | |||||
NBCRO33 | 60 | -60 | 180 | 13 | 14 | 1 | Assays Awaited | |
17 | 19 | 2 | Assays Awaited | |||||
32 | 35 | 3 | Assays Awaited | |||||
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Aldoro Resources Ltd. published this content on 16 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 February 2022 22:53:04 UTC.
